ResMed insider Michael Farrell plans $1.1M sale

RESMED INC (RMD) received a Rule 144 notice for a proposed sale of common stock for the account of Michael J. Farrell.

Rhea-AI Filing Summary

RESMED INC (RMD) received a Rule 144 notice for a proposed sale of common stock for the account of Michael J. Farrell. The filing covers 4,991 shares of common stock, with an indicated aggregate market value of $1,129,064.02, to be sold through Fidelity Brokerage Services LLC on or after September 8, 2026 on the NYSE, in connection with a stock option exercise for cash.

The notice also lists sales during the prior three months, each for 4,991 shares of common stock by Michael Farrell, on June 8, 2026 for $968,064.34, July 7, 2026 for $1,090,770.57, and August 7, 2026 for $1,026,596.29.

Key Figures

Proposed shares to be sold: 4,991 shares Aggregate market value of proposed sale: $1,129,064.02 Prior sale on June 8, 2026: 4,991 shares for $968,064.34 +2 more

5 metrics

Proposed shares to be sold 4,991 shares Common stock proposed for sale for Michael J. Farrell under Rule 144

Aggregate market value of proposed sale $1,129,064.02 Value of 4,991 ResMed common shares proposed to be sold

Prior sale on June 8, 2026 4,991 shares for $968,064.34 ResMed common stock sold by Michael Farrell in preceding three months

Prior sale on July 7, 2026 4,991 shares for $1,090,770.57 ResMed common stock sold by Michael Farrell in preceding three months

Prior sale on August 7, 2026 4,991 shares for $1,026,596.29 ResMed common stock sold by Michael Farrell in preceding three months

Key Terms

Rule 144, stock option exercise, aggregate market value, attorney-in-fact, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock option exercise financial

"Common | 09/08/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common | Fidelity Brokerage Services LLC ... | 4991 | 1129064.02"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact regulatory

"as attorney-in-fact for Michael Farrell"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

common stock financial

"Common | Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What does the latest Form 144 filing report for ResMed (RMD)?

The filing reports that 4,991 shares of ResMed common stock, with an aggregate market value of $1,129,064.02, are proposed to be sold for the account of Michael J. Farrell through Fidelity Brokerage Services LLC on or after September 8, 2026.

Who is the insider involved in the ResMed (RMD) Form 144 filing?

The notice is filed for the account of Michael J. Farrell, identified in the filing in the officer/director section, with proposed sales of ResMed common stock through Fidelity Brokerage Services LLC under Rule 144.

How many ResMed (RMD) shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 4,991 shares of ResMed common stock. The filing indicates an aggregate market value of approximately $1,129,064.02 for these shares, to be sold on or after September 8, 2026 on the NYSE.

What recent ResMed (RMD) share sales by Michael Farrell are disclosed?

The filing lists three prior sales of 4,991 shares each: on June 8, 2026 for $968,064.34, on July 7, 2026 for $1,090,770.57, and on August 7, 2026 for $1,026,596.29, all in ResMed common stock.

What is the relationship between the proposed ResMed (RMD) sale and stock options?

The securities to be sold are described as common stock related to a Stock Option Exercise by the issuer, with the proposed sale of 4,991 shares for cash on or after September 8, 2026.

Which broker is handling the proposed ResMed (RMD) Rule 144 sale?

The proposed sale of 4,991 shares of ResMed common stock is to be handled by Fidelity Brokerage Services LLC, identified with its Smithfield, Rhode Island address in the section describing the securities and proposed sale details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 01:21 PM Accepted by SEC EDGAR 09/08/2026 - 01:21 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001485164
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RESMED INC
SEC File Number	001-15317
Address of Issuer	9001 SPECTRUM CENTER BLVD. SAN DIEGO CALIFORNIA 92123
Phone	8587462400
Name of Person for Whose Account the Securities are To Be Sold	Farrell Michael J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4991	1129064.02	144252306	09/08/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/08/2026	Stock Option Exercise	Issuer			4991	09/08/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	06/08/2026	4991	968064.34
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	07/07/2026	4991	1090770.57
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	08/07/2026	4991	1026596.29

144: Remarks and Signature

Remarks
Date of Notice	09/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/31/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Farrell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)